Annual long term debt:
$845.57M+$472.64M(+126.73%)Summary
- As of today (September 7, 2025), ARWR annual long term debt is $845.57 million, with the most recent change of +$472.64 million (+126.73%) on September 30, 2024.
- During the last 3 years, ARWR annual long term debt has risen by +$822.28 million (+3529.84%).
- ARWR annual long term debt is now at all-time high.
Performance
ARWR Long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly long term debt:
$666.28M-$2.46M(-0.37%)Summary
- As of today (September 7, 2025), ARWR quarterly long term debt is $666.28 million, with the most recent change of -$2.46 million (-0.37%) on June 30, 2025.
- Over the past year, ARWR quarterly long term debt has increased by +$218.21 million (+48.70%).
- ARWR quarterly long term debt is now -22.87% below its all-time high of $863.86 million, reached on December 31, 2024.
Performance
ARWR Quarterly long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
ARWR Long term debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +126.7% | +48.7% |
| 3 y3 years | +3529.8% | +751.7% |
| 5 y5 years | +100.0% | +3172.5% |
ARWR Long term debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +3529.8% | -22.9% | +751.7% |
| 5 y | 5-year | at high | >+9999.0% | -22.9% | +3284.7% |
| alltime | all time | at high | >+9999.0% | -22.9% | >+9999.0% |
ARWR Long term debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $666.28M(-0.4%) |
| Mar 2025 | - | $668.73M(-22.6%) |
| Dec 2024 | - | $863.86M(+2.2%) |
| Sep 2024 | $845.57M(+126.7%) | $845.57M(+88.7%) |
| Jun 2024 | - | $448.07M(+13.6%) |
| Mar 2024 | - | $394.57M(+1.5%) |
| Dec 2023 | - | $388.85M(+4.3%) |
| Sep 2023 | $372.93M(+373.3%) | $372.93M(+366.7%) |
| Jun 2023 | - | $79.91M(-0.2%) |
| Mar 2023 | - | $80.07M(+0.8%) |
| Dec 2022 | - | $79.47M(+0.9%) |
| Sep 2022 | $78.80M(+238.3%) | $78.80M(+0.7%) |
| Jun 2022 | - | $78.23M(+244.7%) |
| Mar 2022 | - | $22.70M(+0.9%) |
| Dec 2021 | - | $22.49M(-3.5%) |
| Sep 2021 | $23.30M(+16.2%) | $23.30M(+1.9%) |
| Jun 2021 | - | $22.85M(+1.4%) |
| Mar 2021 | - | $22.53M(+14.4%) |
| Dec 2020 | - | $19.68M(-1.8%) |
| Sep 2020 | $20.04M(>+9900.0%) | $20.04M(-1.6%) |
| Jun 2020 | - | $20.36M(+43.6%) |
| Mar 2020 | - | $14.18M(-1.4%) |
| Dec 2019 | - | $14.38M(>+9900.0%) |
| Sep 2019 | $0.00(-100.0%) | $0.00(0.0%) |
| Jun 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | - | $0.00(-100.0%) |
| Sep 2018 | $2.10M(-9.6%) | $2.10M(-2.7%) |
| Jun 2018 | - | $2.16M(-2.6%) |
| Mar 2018 | - | $2.22M(-2.4%) |
| Dec 2017 | - | $2.27M(-2.3%) |
| Sep 2017 | $2.33M(-8.2%) | $2.33M(-2.2%) |
| Jun 2017 | - | $2.38M(-2.2%) |
| Mar 2017 | - | $2.43M(-2.1%) |
| Dec 2016 | - | $2.48M(-2.0%) |
| Sep 2016 | $2.53M(+368.5%) | $2.53M(-14.5%) |
| Jun 2016 | - | $2.96M(+587.8%) |
| Mar 2016 | - | $430.70K(-11.3%) |
| Dec 2015 | - | $485.80K(-10.2%) |
| Sep 2015 | $540.80K(-28.7%) | $540.80K(-9.2%) |
| Jun 2015 | - | $595.50K(-8.4%) |
| Mar 2015 | - | $650.00K(-7.8%) |
| Dec 2014 | - | $705.20K(-7.0%) |
| Sep 2014 | $758.30K(-31.8%) | $758.30K(-6.6%) |
| Jun 2014 | - | $812.20K(-6.2%) |
| Mar 2014 | - | $865.80K(-14.0%) |
| Dec 2013 | - | $1.01M(-9.4%) |
| Sep 2013 | $1.11M(-47.6%) | $1.11M(-4.8%) |
| Jun 2013 | - | $1.17M(-4.5%) |
| Mar 2013 | - | $1.22M(-4.3%) |
| Dec 2012 | - | $1.28M(-39.8%) |
| Sep 2012 | $2.12M | $2.12M(-0.4%) |
| Jun 2012 | - | $2.13M(-0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $2.14M(-0.4%) |
| Dec 2011 | - | $2.15M(+253.8%) |
| Sep 2011 | $606.80K(>+9900.0%) | $606.80K(+8.2%) |
| Jun 2011 | - | $560.90K(+7.9%) |
| Mar 2011 | - | $519.70K(>+9900.0%) |
| Dec 2010 | - | $0.00(0.0%) |
| Sep 2010 | $0.00(-100.0%) | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | - | $0.00(-100.0%) |
| Sep 2009 | $500.00K(-31.2%) | $500.00K(-13.0%) |
| Jun 2009 | - | $574.80K(-79.6%) |
| Mar 2009 | - | $2.81M(-7.2%) |
| Dec 2008 | - | $3.03M(+317.1%) |
| Sep 2008 | $726.50K(>+9900.0%) | $726.50K(>+9900.0%) |
| Jun 2008 | - | $0.00(0.0%) |
| Mar 2008 | - | $0.00(0.0%) |
| Dec 2007 | - | $0.00(0.0%) |
| Sep 2007 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | - | $0.00(0.0%) |
| Sep 2006 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) |
| Dec 2005 | - | $0.00(0.0%) |
| Sep 2005 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) |
| Sep 2004 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2004 | - | $0.00(0.0%) |
| Mar 2004 | - | $0.00(0.0%) |
| Dec 2003 | - | $0.00(0.0%) |
| Sep 2003 | $0.00(-100.0%) | $0.00(-100.0%) |
| Jun 2003 | - | $27.50K(0.0%) |
| Mar 2003 | - | $27.50K(+5.8%) |
| Dec 2002 | - | $26.00K(-5.5%) |
| Sep 2002 | $27.50K(-16.7%) | $27.50K(-5.2%) |
| Jun 2002 | - | $29.00K(-4.9%) |
| Mar 2002 | - | $30.50K(-4.7%) |
| Dec 2001 | - | $32.00K(-3.0%) |
| Sep 2001 | $33.00K(-15.4%) | $33.00K(-4.3%) |
| Jun 2001 | - | $34.50K(-4.2%) |
| Mar 2001 | - | $36.00K(-4.0%) |
| Dec 2000 | - | $37.50K(-3.8%) |
| Sep 2000 | $39.00K(-9.3%) | $39.00K(-3.7%) |
| Jun 2000 | - | $40.50K(+3.8%) |
| Mar 2000 | - | $39.00K(-1.3%) |
| Dec 1999 | - | $39.50K(-8.1%) |
| Sep 1999 | $43.00K(-4.4%) | $43.00K(-1.1%) |
| Jun 1999 | - | $43.50K(-1.1%) |
| Mar 1999 | - | $44.00K |
| Sep 1998 | $45.00K | - |
FAQ
- What is Arrowhead Pharmaceuticals, Inc. annual long term debt?
- What is the all time high annual long term debt for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. annual long term debt year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. quarterly long term debt?
- What is the all time high quarterly long term debt for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. quarterly long term debt year-on-year change?
What is Arrowhead Pharmaceuticals, Inc. annual long term debt?
The current annual long term debt of ARWR is $845.57M
What is the all time high annual long term debt for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high annual long term debt is $845.57M
What is Arrowhead Pharmaceuticals, Inc. annual long term debt year-on-year change?
Over the past year, ARWR annual long term debt has changed by +$472.64M (+126.73%)
What is Arrowhead Pharmaceuticals, Inc. quarterly long term debt?
The current quarterly long term debt of ARWR is $666.28M
What is the all time high quarterly long term debt for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high quarterly long term debt is $863.86M
What is Arrowhead Pharmaceuticals, Inc. quarterly long term debt year-on-year change?
Over the past year, ARWR quarterly long term debt has changed by +$218.21M (+48.70%)